Skip to main content

Overcoming the Barriers of Brain Cancer Treatment: Targeted and Fully NIR Absorbing Photodynamic Therapy Agents with Extremely Low Molecular Weights and Controlled Lipophilicity

Project description

Photodynamic therapy for brain tumours

Brain cancer has a dismal five-year survival rate due to the high percentage of inoperable tumours and the limited number of drugs that can pass through the blood–brain barrier. Therefore, there is an imminent need for effective targeted brain cancer therapies. Scientists of the EU-funded INFRADYNAMICS project are working on photodynamic therapy (PDT), a type of therapy that combines light and a photosensitising drug to kill cancer cells. The key objective is to develop PDT agents capable of specific deep tissue penetration, infrared light absorption and high oxygen generation efficiency. Alongside the characterisation of their photophysical properties, the generated PDT agents will be tested on glioblastoma cells for effectiveness.

Call for proposal

ERC-2019-STG
See other projects for this call

Host institution

MIDDLE EAST TECHNICAL UNIVERSITY
Address
Dumlupinar Bulvari 1
06800 Ankara
Turkey
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 500 000

Beneficiaries (1)

MIDDLE EAST TECHNICAL UNIVERSITY
Turkey
EU contribution
€ 1 500 000
Address
Dumlupinar Bulvari 1
06800 Ankara
Activity type
Higher or Secondary Education Establishments